HCCANANO-HOPE1: IRE After Chemotherapy for Locally Advanced Unresectable Perihilar Cholangiocarcinoma | MicrobiomeTrials← Back to trialsNCT07795619
HCCANANO-HOPE1: IRE After Chemotherapy for Locally Advanced Unresectable Perihilar Cholangiocarcinoma
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-04-01Est. Completion: 2026-12-31
Enrollment target: 60 participants Locations- Tianjin Cancer Hospital Airport Hospital, Tianjin, Tianjin Municipality, China
Other microbiome trials you might be interested in
Prostate Cancer
Conventional treatment options for localized prostate cancer include prostatectomy, radiotherapy and active surveillance…
Hong Kong, Hong KongEst. completion Jan 31, 2027
Atherosclerosis Cardiovascular Disease
Background:
Hypertension (HT) is the most common condition worldwide, predisposing to atherosclerotic disease. However,…
Shatin, Hong KongEst. completion Jul 30, 2027
Non-small Cell Lung Cancer
This is a Phase 2/3, multisite, randomized, open-label study in participants with first-line non-small cell lung cancer …
Birmingham, United StatesEst. completion Jan 2029